A Multibiomarker-Based Outcome Risk Stratification Model for Adult Septic Shock

被引:97
|
作者
Wong, Hector R. [1 ,2 ,3 ]
Lindsell, Christopher J. [4 ]
Pettilae, Ville [5 ]
Meyer, Nuala J. [6 ]
Thair, Simone A. [7 ,8 ]
Karlsson, Sari [9 ]
Russell, James A. [7 ,8 ]
Fjell, Christopher D. [7 ,8 ]
Boyd, John H. [7 ,8 ]
Ruokonen, Esko [10 ]
Shashaty, Michael G. S. [6 ]
Christie, Jason D. [6 ,11 ]
Hart, Kimberly W. [4 ]
Lahni, Patrick [1 ,2 ]
Walley, Keith R. [7 ,8 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA
[2] Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH USA
[3] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[4] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA
[5] Univ Helsinki, Cent Hosp, Dept Surg, Intens Care Units,Div Anaesthesia & Intens Care M, Helsinki, Finland
[6] Univ Penn, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA
[7] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[8] St Pauls Hosp, Ctr Heart Lung Innovat, Crit Care Res Labs, Vancouver, BC V6Z 1Y6, Canada
[9] Tampere Univ Hosp, Dept Intens Care Med, Tampere, Finland
[10] Kuopio Univ Hosp, Dept Intens Care Med, SF-70210 Kuopio, Finland
[11] Univ Penn, Ctr Clin Epidemiol & Biostat, Dept Epidemiol, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
biomarkers; decision tree; modeling; outcome; sepsis; stratification; SEVERE SEPSIS; PREDICTION MODELS; SURVIVING SEPSIS; EXPRESSION; MORTALITY; PERFORMANCE; BIOMARKERS; CAMPAIGN; THERAPY;
D O I
10.1097/CCM.0000000000000106
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Clinical trials in septic shock continue to fail due, in part, to inequitable and sometimes unknown distribution of baseline mortality risk between study arms. Investigators advocate that interventional trials in septic shock require effective outcome risk stratification. We derived and tested a multibiomarker-based approach to estimate mortality risk in adults with septic shock. Design: Previous genome-wide expression studies identified 12 plasma proteins as candidates for biomarker-based risk stratification. The current analysis used banked plasma samples and clinical data from existing studies. Biomarkers were assayed in plasma samples obtained from 341 subjects with septic shock within 24 hours of admission to the ICU. Classification and regression tree analysis was used to generate a decision tree predicting 28-day mortality based on a combination of both biomarkers and clinical variables. The derived tree was first tested in an independent cohort of 331 subjects, then calibrated using all subjects (n = 672), and subsequently validated in another independent cohort (n = 209). Setting: Multiple ICUs in Canada, Finland, and the United States. Subjects: Eight hundred eighty-one adults with septic shock or severe sepsis. Intervention: None. Measurements and Main Results: The derived decision tree included five candidate biomarkers, admission lactate concentration, age, and chronic disease burden. In the derivation cohort, sensitivity for mortality was 94% (95% CI, 87-97), specificity was 56% (50-63), positive predictive value was 50% (43-57), and negative predictive value was 95% (89-98). Performance was comparable in the test cohort. The calibrated decision tree had the following test characteristics in the validation cohort: sensitivity 85% (76-92), specificity 60% (51-69), positive predictive value 61% (52-70), and negative predictive value 85% (75-91). Conclusions: We have derived, tested, calibrated, and validated a risk stratification tool and found that it reliably estimates the probability of mortality in adults with septic shock.
引用
收藏
页码:781 / 789
页数:9
相关论文
共 50 条
  • [41] Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease A monocenter retrospective study in China
    Ma, Jie
    Li, Ning
    Liu, Yajie
    Wang, Chong
    Liu, Xiaoyan
    Chen, Shengmei
    Xie, Xinsheng
    Gan, Silin
    Wang, Meng
    Cao, Weijie
    Wang, Fang
    Liu, Yanfan
    Wan, Dingming
    Sun, Ling
    Sun, Hui
    MEDICINE, 2017, 96 (21)
  • [42] The Effect of Early Goal-Directed Therapy On Outcome in Adult Severe Sepsis And Septic Shock Patients: A Meta-Analysis of Randomised Clinical Trials
    J Xu
    Y Yang
    H Qiu
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [43] Surgeon-specific risk stratification model for early complications after complex adult spinal deformity surgery
    Li, Xudong J.
    Lenke, Lawrence G.
    Jin, Li
    Tuchman, Alexander
    Tan, Lee A.
    Lehman, Ronald A.
    Cerpa, Meghan
    SPINE DEFORMITY, 2020, 8 (01) : 97 - 104
  • [44] The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma
    Johnson, Sarah K.
    Heuck, Christoph J.
    Albino, Anthony P.
    Qu, Pingping
    Zhang, Qing
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (04) : 321 - 333
  • [45] Diagnostic Validation of the Updated Pediatric Sepsis Biomarker Risk II for Acute Kidney Injury Prediction Model in Pediatric Septic Shock
    Stanski, Natalja L.
    Zhang, Bin
    Cvijanovich, Natalie Z.
    Fitzgerald, Julie C.
    Bigham, Michael T.
    Jain, Parag N.
    Schwarz, Adam J.
    Lutfi, Riad
    Allen, Geoffrey L.
    Thomas, Neal J.
    Baines, Torrey
    Haileselassie, Bereketeab
    Weiss, Scott L.
    Atreya, Mihir R.
    Lautz, Andrew J.
    Zingarelli, Basilia
    Standage, Stephen W.
    Kaplan, Jennifer
    Goldstein, Stuart L.
    PEDIATRIC CRITICAL CARE MEDICINE, 2024, 25 (11) : 1005 - 1016
  • [46] Aryl Hydrocarbon Receptor Activation by Benzo[a]pyrene Prevents Development of Septic Shock and Fatal Outcome in a Mouse Model of Systemic Salmonella enterica Infection
    Fueldner, Christiane
    Riemschneider, Sina
    Haupt, Janine
    Jungnickel, Harald
    Schulze, Felix
    Zoldan, Katharina
    Esser, Charlotte
    Hauschildt, Sunna
    Knauer, Jens
    Luch, Andreas
    Kalkhof, Stefan
    Lehmann, Joerg
    CELLS, 2022, 11 (04)
  • [47] Application of neutrophil-to-lymphocyte-to-monocyte ratio in predicting mortality risk in adult patients with septic shock: A retrospective cohort study conducted at a single center
    Lin, Xiao-ming
    Zhang, Lian-fang
    Wang, Yu-ting
    Huang, Ting
    Lin, Xue-feng
    Hong, Xiang-yu
    Zheng, Hong-jun
    Xie, Rong-cheng
    Ma, Jie-fei
    HELIYON, 2024, 10 (07)
  • [48] The Proteasome-Family-Members-Based Prognostic Model Improves the Risk Classification for Adult Acute Myeloid Leukemia
    Sheng, Guangying
    Tao, Jingfen
    Jin, Peng
    Li, Yilu
    Jin, Wen
    Wang, Kankan
    BIOMEDICINES, 2024, 12 (09)
  • [49] Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA
    Caviglia, Gian Paolo
    Fariselli, Piero
    D'Ambrosio, Roberta
    Colombatto, Piero
    Degasperi, Elisabetta
    Ricco, Gabriele
    Abate, Maria Lorena
    Birolo, Giovanni
    Troshina, Giulia
    Damone, Francesco
    Coco, Barbara
    Cavallone, Daniela
    Perbellini, Riccardo
    Monico, Sara
    Saracco, Giorgio Maria
    Brunetto, Maurizia Rossana
    Lampertico, Pietro
    Ciancio, Alessia
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (03) : 538 - 549
  • [50] Prostate Cancer Screening Using Risk Stratification Based on a Multi-State Model of Genetic Variants
    Yen, Amy Ming-Fang
    Auvinen, Anssi
    Schleutker, Johanna
    Wu, Yi-Ying
    Fann, Jean Ching-Yuan
    Tammela, Teuvo
    Chen, Sam Li-Sheng
    Chiu, Sherry Yueh-Hsia
    Chen, Hsiu-Hsi
    PROSTATE, 2015, 75 (08) : 825 - 835